Growing community of inventors

Macclesfield, United Kingdom

Ian Alun Nash

Average Co-Inventor Count = 2.73

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Ian Alun NashDearg Sutherland Brown (3 patents)Ian Alun NashJohn Graham Cumming (2 patents)Ian Alun NashNicola Frances Bateman (5 patents)Ian Alun NashPaul Allen Bethel (1 patent)Ian Alun NashJonathan Erle Finlayson (1 patent)Ian Alun NashKenneth Mark Page (1 patent)Ian Alun NashCaroline Rachel Thompson (1 patent)Ian Alun NashPhilip Alexander Macfaul (0 patent)Ian Alun NashIan Alun Nash (5 patents)Dearg Sutherland BrownDearg Sutherland Brown (20 patents)John Graham CummingJohn Graham Cumming (11 patents)Nicola Frances BatemanNicola Frances Bateman (5 patents)Paul Allen BethelPaul Allen Bethel (1 patent)Jonathan Erle FinlaysonJonathan Erle Finlayson (1 patent)Kenneth Mark PageKenneth Mark Page (1 patent)Caroline Rachel ThompsonCaroline Rachel Thompson (1 patent)Philip Alexander MacfaulPhilip Alexander Macfaul (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Astrazeneca Ab (4 from 1,500 patents)

2. Asrazeneca Ab (1 from 1 patent)


5 patents:

1. 8742124 - Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors

2. 7943776 - Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors

3. 7786115 - Amide derivatives

4. 7750154 - Amide derivatives

5. 7696215 - 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/6/2026
Loading…